致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Cynomolgus LILRB4/CD85k/ILT3, His-tag
目录号 NBL-240762
别名 LILRB4/CD85k/ILT3; HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
外观 see COA
分子量 Gln22-Glu259
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 XP_015297198.1
备注2
目录号 规格 价格 库存状态  
NBL-240762-100ug 100ug Inquire Inquire
NBL-240762-1mg 1mg Inquire Inquire
NBL-240762-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Cynomolgus LILRB4/CD85k/ILT3, His-tag


Catalog#:

NBL-240762


Description:

NebuSelect™ Recombinant Cynomolgus LILRB4/CD85k/ILT3, His-tag(Cat#NBL-240762) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln22-Glu259.


Species:

Cynomolgus


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 27.2 kDa. Due to glycosylation, the protein migrates to 35-42 kDa based on Bis-Tris PAGE result.


Target Name:

LILRB4/CD85k/ILT3; HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K


Target Information:

LILRB4,also known as CD85k and LIR-5, ILT3,- is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT3 consists of a 238 amino acid (aa) extracellular domain with two Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM).LILRB4 is receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles.


Amino Acid Sequence: 

Gln22-Glu259


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品